Fibrinogen mediates cadmium-induced macrophage activation and serves as a predictor of cadmium exposure in chronic obstructive pulmonary disease
- 1 April 2022
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 322 (4) , L593-L606
Abstract
The etiologies of chronic obstructive pulmonary disease (COPD) remain unclear. Cadmium (Cd) causes both pulmonary fibrosis and emphysema; however, the predictors for Cd exposure and the mechanisms by which Cd causes COPD remain unknown. We demonstrated that Cd burden was increased in lung tissue from subjects with COPD and this was associated with cigarette smoking. Fibrinogen levels increased markedly in lung tissue of patients with smoked COPD compared with never-smokers and control subjects. Fibrinogen concentration also correlated positively with lung Cd load, but inversely with the predicted % of FEV1 and FEV1/FVC. Cd enhanced the secretion of fibrinogen in a cdc2-dependent manner, whereas fibrinogen further mediated Cd-induced peptidylarginine deiminase 2 (PAD2)-dependent macrophage activation. Using lung fibroblasts from CdCl2-treated Toll-like receptor 4 (TLR4) wild-type and mutant mice, we demonstrated that fibrinogen enhanced Cd-induced TLR4-dependent collagen synthesis and cytokine/chemokine production. We further showed that fibrinogen complexed with connective tissue growth factor (CTGF), which in turn promoted the synthesis of plasminogen activator inhibitor-2 (PAI-2) and fibrinogen and inhibited fibrinolysis in Cd-treated mice. The amounts of fibrinogen were increased in the bronchoalveolar lavage fluid (BALF) of Cd-exposed mice. Positive correlations were observed between fibrinogen with hydroxyproline. Our data suggest that fibrinogen is involved in Cd-induced macrophage activation and increases in fibrinogen in patients with COPD may be used as a marker of Cd exposure and predict disease progression.Keywords
Funding Information
- HHS | NIH | National Institute of Environmental Health Sciences (P42 ES027723)
- HHS | NIH | National Institute of Environmental Health Sciences (RO1 ES029981)
- HHS | NIH | National Institute of Environmental Health Sciences (U54 ES030246)
This publication has 66 references indexed in Scilit:
- Blood fibrinogen as a biomarker of chronic obstructive pulmonary disease: Table 1Thorax, 2012
- Therapeutic Value of Small Molecule Inhibitor to Plasminogen Activator Inhibitor–1 for Lung FibrosisAmerican Journal of Respiratory Cell and Molecular Biology, 2012
- The vitronectin-binding function of PAI-1 exacerbates lung fibrosis in miceBlood, 2011
- Wood Bark Smoke Induces Lung and Pleural Plasminogen Activator Inhibitor 1 and Stabilizes Its mRNA in Porcine Lung CellsShock, 2011
- Connective Tissue Growth Factor (CTGF/CCN2) enhances lactogenic differentiation of mammary epithelial cells via integrin-mediated cell adhesionBMC Cell Biology, 2010
- Characterization of PM10 and PM2.5 and associated heavy metals at the crossroads and urban background site in Zabrze, Upper Silesia, Poland, during the smog episodesEnvironmental Monitoring and Assessment, 2009
- Enhanced fibrinolysis protects against lung ischemia–reperfusion injuryThe Journal of Thoracic and Cardiovascular Surgery, 2009
- Human Fibroblasts Bind Directly to Fibrinogen at RGD Sites through Integrin αvβ3Experimental Cell Research, 1997
- Heparin-Binding Domain of Fibrin Mediates Its Binding to Endothelial CellsArteriosclerosis, Thrombosis, and Vascular Biology, 1996
- The Relations between Structural Changes in Small Airways and Pulmonary-Function TestsNew England Journal of Medicine, 1978